Automated Kinetic Confocal Imaging

BD Pathway 855 High Content Bioimager

Fluofarma has integrated a High Content Screening platform based on automated kinetic confocal imaging.
This confocal imaging platform allows high-resolution images analysis in living cells. This enables the assessment in real time of the effects of compounds on phenotypic and molecular events, and thus allows the understanding of the kinetics of those events.

► Automated Platform: from liquid handling to data analysis

► Versatility and flexibility:

Multiple slide and multiwell plate formats
Fixed cells, suspension or loosely adherent cells
Controlled imaging chamber for live cell experimentation
Laser-free illumination, large spectrum of fluorescent dyes

► Fast and efficient:

High quality images and reduced background fluorescence
Easy conversion of endpoint assays to kinetic applications
Flexible software: easy data classification & analysis

BD Pathway 855 High-Content Bioimager

Breaking news

  • High Content Analysis 2012

    Fluofarma will be attending the High Content Analysis 2012 in San Francisco, from January 9th to 12th. We look forward to seeing you at our booth (n° 34) and your are welcome the 11th at the « Luncheon Technology Showcase: High-Content Data Analysis » where Fluofarma will present CytoSurfe®r. An innovative and intuitive software application for High content image analysis.

    Read more [+]

  • Scientific Publication

    Fluofarma is glad to announce a new scientific publication in the journal "The American Journal of Pathology".

    Read more [+]